Kevin Sides
Family Medicine · Festus, MONPI 1821096652
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 127 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AbbVie at 47.4% of the total. Reporting peaked in 2021 at $647 and has fallen 95.8% since, to $27 in 2023.
Across 127 payments — averaging $16.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$183
- GSK$170
- Amarin Pharma, Inc.$132
- AstraZeneca$109
- Merck$67
- plus $457 from 14 others
What the payments were for
- Food & beverage$2,124100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 46 | $1,006 |
| Novo Nordisk | 12 | $183 |
| GSK | 15 | $170 |
| Amarin Pharma, Inc. | 9 | $132 |
| AstraZeneca | 8 | $109 |
| Merck | 5 | $67 |
| Johnson & Johnson | 4 | $58 |
| Novartis | 4 | $58 |
| Astellas Pharma US Inc | 3 | $56 |
| Lilly USA, LLC | 4 | $51 |
| Boehringer Ingelheim | 4 | $49 |
| Arbor Pharmaceuticals, Inc. | 3 | $36 |
| Amgen | 2 | $35 |
| Pfizer | 2 | $28 |
| Mylan Specialty L.p. | 1 | $24 |
| Radius Health, Inc. | 1 | $13 |
| Sunovion Pharmaceuticals Inc. | 1 | $12 |
| Regeneron Healthcare Solutions, Inc. | 1 | $12 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
| Biohaven Pharmaceuticals, Inc. | 1 | $11 |
How this compares
$2,124 in reported general payments places this provider in the 75th percentile of 2,203 family medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Soliqua 100-33Insulin Glargine/Lixisenatide | 17 | $5,369 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 11 | $1,437 |
| Atorvastatin Calcium | 19 | $321 |
| Lisinopril | 20 | $157 |
| Risperidone | 14 | $132 |
| Famotidine | 14 | $107 |
| Metformin Hcl | 14 | $98 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Festus
- Leah SilverFestus$32K
- Anthony AndersonFestus$19K
- Stephen AdamsSpringfield$636K
- Justin PuckettKirksville$568K
- Matthew BeckerditeOfallon$225K
- Roger CadySpringfield$175K
- James LasalleExcelsior Springs$130K
- Matthew TiefenbrunnSullivan$105K
- Ayobami OduwoleGrandview$92K
- Michael DonovanSaint Louis$78K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.